The CDC's Advisory Committee on Immunization Practices meets Wednesday for a four-hour meeting to review Pfizer and BioNTech's Covid-19 booster shots for kids ages 12 to 15.
The Food and Drug Administration expanded the eligibility of the shots to adolescents on Monday. The FDA said no new safety concerns had emerged after evaluating real-world data from Israel on 6,300 kids ages 12 through 15 who received a Pfizer booster dose.
» Subscribe to CNBC TV: [ Ссылка ]
» Subscribe to CNBC: [ Ссылка ]
» Subscribe to CNBC Classic: [ Ссылка ]
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.
Connect with CNBC News Online
Get the latest news: [ Ссылка ]
Follow CNBC on LinkedIn: [ Ссылка ]
Follow CNBC News on Facebook: [ Ссылка ]
Follow CNBC News on Twitter: [ Ссылка ]
Follow CNBC News on Instagram: [ Ссылка ]
#CNBC
#CNBCTV
CDC panel meets to discuss Pfizer’s Covid booster shots for adolescents — 1/5/2022
